DNTH (Dianthus Therapeutics) Forvard P/E multiplikatori

Dianthus Pharma (DNTH) kompaniyasining korporativ logotipi

Dianthus Therapeutics (DNTH) o'zining noyob patentlariga tayangan holda, autoimmun patologiya terapiyasi bo'yicha yetakchilik uchun yuqori xavfli kurash olib bormoqda. Kam uchraydigan surunkali tashxisga e'tibor qaratish kompaniyaga tor nishalarda uzoq muddatli daromadni ta'minlaydi. GURU.Markets terminali kompaniyaning konsensus prognozli P/E ko'rsatkichini taqdim etadi, bunda 0.00 yangi darajani belgilaydi. Biroq, daromadli aktivlarning yo'qligi biznesni tashqi investitsiyalarga bog'liq holda qoldiradi.

Prognoz qilingan narxning foydaga nisbati: Dianthus Therapeutics, Inc. (DNTH) 21.02.2024 - 15.11.2026 uchun

Dianthus Therapeutics kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahliliyoti:dianthustx.com
Dianthus Therapeutics tovar namunasi

Dianthus Therapeutics (DNTH) kamyob autoimmun patologiyalar sohasida qimmat tadqiqot va ishlanmalar (R&D) loyihalarini ishlab chiqmoqda. Ushbu kutilayotgan narx-foyda koeffitsienti kompaniyaning joriy bozor qiymatini prognoz qilingan daromadlar bilan solishtiradi. Ushbu ko'rsatkich kotirovkalar haqiqiy moliyaviy istiqbollardan tezroq ko'tarilganda aktivning haddan tashqari qimmat baholanganligini ochib beradi. Biofarmatsevtika sohasi uchun klinik sinovlarning beqarorligi tufayli ushbu farq kritik ahamiyatga ega. Yuqori koeffitsient spekulyativ pufakning mavjudligini va keskin korreksiya xavfini bildiradi.

Dianthus Therapeutics (DNTH) raqobatchilari

Prognoz qilingan narxning foydaga nisbati ARGX (Argenx)|BNTX (BioNTech Group) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (Abivax SA)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati admabiologics.com (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|Immunovant Inc (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa Corp (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols, S.A.|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori celldex.com|Kelajakdagi narxning foydaga nisbati Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (veratx.com)|Pharvaris Pharma (PHVS) - Prognoz qilingan narx-foyda nisbati|AbCellera Biologics - Forvard P/E multiplikatori|tourmalinebio.com - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Precigen (PGEN) - Kelajakdagi narxning foydaga nisbati|Pharming Group - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Nektar Therapeutics Inc|UPB (Upstream Pharma) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori ZBIO|Forvard P/E multiplikatori immunome.com (IMNM)|Forvard P/E multiplikatori GOSS (gossamerbio.com)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati KalVista Pharma (KALV)|SEPN - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Prognoz qilingan narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - Forvard P/E multiplikatori|ATXS (Astria Therapeutics, Inc.) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Kelajakdagi narxning foydaga nisbati engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Kelajakdagi narx-foyda multiplikatori|Aerovate Therapeutics - Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori ACRS|Kyverna Therapeutics, Inc - Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati TLSA|CABA: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Ventyx Bio|Kelajakdagi narxning foydaga nisbati Theratechnologies, Inc.|Prognoz qilingan narx-foyda nisbati Avalo Therapeutics AVTX|Forvard P/E multiplikatori ELDN|AGEN (Agenus, Inc.) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Prognoz qilingan narx-foyda nisbati|ATYR: Prognoz qilingan narxning foydaga nisbati|adagene.com (ADAG) - Prognoz qilingan narxning foydaga nisbati|Ikena Oncology (IMA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Shattuck Labs, Inc.|Kelajakdagi narxning foydaga nisbati equilliumbio.com|Prognoz qilingan narxning foydaga nisbati connectbiopharm.com (CNTB)|Forvard P/E multiplikatori IMUX|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Atara Bio|Kelajakdagi narxning foydaga nisbati InflaRx N.V. IFRX|X4 Pharmaceuticals - Kelajakdagi narxning foydaga nisbati|ACET: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CELU (celularity.com)|INMB: Forvard P/E multiplikatori|BRNS: Kapitalizatsiyaning kelajakdagi foydaga nisbati|KZR (Kezar Life Sciences, Inc.) - Forvard P/E multiplikatori|SAB Biotherapeutics Inc. (SABS) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori AKTX|Kelajakdagi narxning foydaga nisbati ENLV (Enlivex Therapeutics Ltd)|Kelajakdagi narxning foydaga nisbati Q32 Bio Inc. QTTB|GOVX - Prognoz qilingan narxning foydaga nisbati|EDSA - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati iBio|CARM: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati XTLB (XTL Biopharmaceuticals, Ltd.)|Kelajakdagi narxning foydaga nisbati boltbio.com|Forvard P/E multiplikatori HCW Biologics|Forvard P/E multiplikatori APVO|AIM - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori ADTX (Aditxt Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati GRI Bio, Inc. (GRI)|XRTX - Kelajakdagi narxning foydaga nisbati|reshapelifesciences.com (HIND) - Prognoz qilingan narxning foydaga nisbati|REVB: Forvard P/E multiplikatori|Indaptus Therapeutics, Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Scinai|Prognoz qilingan narx-foyda nisbati CalciMedica, Inc. CALI|Kelajakdagi narxning foydaga nisbati Affimed NV (AFMD)|Forvard P/E multiplikatori Allakos Inc (ALLK)|Kelajakdagi narxning foydaga nisbati hookipapharma.com HOOK|Forvard P/E multiplikatori IGM Biosciences, Inc. IGMS|iTeos Pharma - Forvard P/E multiplikatori|OCEA - Forvard P/E multiplikatori|TCBP: Forvard P/E multiplikatori|Third Harmonic Bio - Kelajakdagi narx-foyda multiplikatori